Increasing Prevalence of Chronic Disorders and Approval and Launch of New Products to Augment Growth of Medical Membrane Market
Advancements
in medical sciences, rising incidences of fatal diseases, improvement in
medical technology, growth in pharmaceutical and medical industry, increased
demand for safe medicines and pharmaceutical products are some of the major
driving forces that are expected to drive the medical membrane industry for
hematological application and other pharmaceutical purification process.
Medical
membranes, which help to safeguard different biological resources are extremely
important as they help in protecting our health from various deadly and
contagious diseases. These applications include the manufacturing of customized
biocompatible solutions for the protection and purification of biological
fluids. This industry is witnessing an exponential growth with constant inflow
of pharmaceutical products, research and development activities. As per the
statistics, there has been a steady rise in the demand for medical devices,
materials and equipment that are required for the purification of medicines.
With the right purification procedure, the drugs present in the body can remain
active and the harmful chemicals out of the system can be avoided.
Market Dynamics
Increasing
prevalence of chronic disorders is expected to propel growth of the global medical
membrane market. For instance, according to the study, ‘Risk Factors and
Rate of Progression of CKD in Children’, published in June 2019 in Kidney
International Reports, 38% children experienced progression of chronic kidney
disease within 2 years of follow-up.
The
global medical membrane market is witnessing several M&A activities. For
instance, in December 2020, Collagen Matrix, Inc., a regenerative,
collagen-based, xenograft-derived medical devices provider, acquired Sunstar's
Degradable Solutions division including its GUIDOR branded line of resorbable
synthetic medical implants. Similarly, in January 2021, Blue Earth Diagnostics,
a Bracco company, signed an exclusive, worldwide agreement with Scintomics
GmbH, Germany, a specialist in radiopharmaceuticals and radiopharmaceutical
technologies, and the Technical University of Munich, to acquire exclusive,
worldwide rights to therapeutic applications of novel radiohybrid
Prostate-Specific Membrane Antigen technology in prostate cancer.
Among
regions, North America is expected to witness significant growth in the global
medical membrane market, owing to high prevalence of cancer in the region. For
instance, according to the American Cancer Society, in 2019, there will be an
estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the
U.S.
Competitive Analysis
Major
players operating in the global medical membrane market include, Nipro
Corporation, Amniox, Pall Corporation, Sorin Group, Gore, OXGENE, Maquet
Company, Merck Millipore, and others.
Major
players operating in the global medical membrane market are focused on approval
and launch of new products to expand their product portfolio. For instance, in
January 2021, OXGENE, a biotechnology company offering integrated discovery and
manufacturing technologies to the cell and gene therapy industry, launched its
self-labelling integral membrane (SLIM) protein discovery system.
Comments
Post a Comment